Delivery Order 75N91023D00010-75N91023F00001
Award Date
7/1/23
Potential Completion Date
6/30/28
Potential Value
$27M
Federal Agency
National Cancer Institute
Awardee
Mriglobal
Ultimate Awardee
Not listed
NAICS Category
541690 - Other Scientific and Technical Consulting Services
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Kansas City, MO 64110, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $25,543,276.37 cost-plus-fixed-fee definitive contract awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to the not-for-profit research organization Mriglobal (doing business as Midwest Research Institute). The contract is for the analysis of anti-cancer chemicals and pharmaceutical formulations.
Mriglobal is a highly experienced federal contractor, holding several significant...
This is a $790,714 delivery order awarded by the National Cancer Institute, a civilian agency within the U.S. Department of Health and Human Services, to Mriglobal (doing business as Midwest Research Institute). The contract is for the evaluation of the shelf-life of samples of investigational clinical drug formulations, including parenteral, oral, and other dosage forms. This delivery order is issued under the Drug Formulation and Manufacturing Contracts 2019 multiple-award...
This federal contract award is for $17,180,292.00 and was made to Mriglobal, doing business as Midwest Research Institute, a 501(c)(3) not-for-profit research organization. The contract is for biomedical management and support services, with a period of performance ending on July 31, 2007. It is a cost-plus-award-fee type contract, and there is no set-aside designation.
Mriglobal specializes in areas such as medical countermeasure development, biosafety testing, threat detection technologies,...
This contract award, valued at $17,402,019.28, is for the provision of a Centralized Chemopreventive Agent Repository and Chemistry Support. The prime contractor is MRIGlobal, a non-profit research organization that provides scientific research, testing, and product development services to federal and commercial clients, particularly in the areas of medical countermeasure development, biosafety testing, and specialized training programs.
The contract has a variety of subcontractors, including...
This federal contract award is for DRUG SHELF LIFE TESTING, with a ceiling value of $1,829,304.80. The contract was awarded to Mriglobal, doing business as Midwest Research Institute, a 501(c)(3) not-for-profit research organization, by the National Cancer Institute, a civilian agency within the U.S. Department of Health and Human Services. The contract is a Definitive Contract with a Cost Plus Fixed Fee pricing type. The contract does not have a set-aside designation. Mriglobal has received...
This is a delivery order awarded to Mriglobal, doing business as Midwest Research Institute, under a $3,500.00 Firm Fixed Price Indefinite Delivery/Indefinite Quantity (IDIQ) contract. The contract was awarded by the National Institute of Allergy and Infectious Diseases, a civilian agency, for the Diagnostics Pre-Clinical Services Program. The contract has a period of performance through June 19, 2030. Mriglobal is a 501(c)(3) not-for-profit research organization that provides scientific...
This is a delivery order federal contract awarded by the National Cancer Institute, a civilian agency under the Department of Health and Human Services, to Mriglobal, doing business as Midwest Research Institute, a 501(c)(3) not-for-profit research organization. The $1,524,929.00 contract is for the manufacture of plasmid DNA drug substance and drug product. The period of performance runs through September 24, 2027.
Mriglobal has been awarded multiple significant federal contracts and grants...
This is a $500,000.00 definitive contract awarded by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) to Mriglobal, doing business as Midwest Research Institute, a not-for-profit research organization. The contract is for IGF::OT::IGF FOR OTHER FUNCTIONS with a completion date of September 24, 2019. It is a firm fixed-price contract and was not set aside for any specific business type. Mriglobal conducts over $110 million in research annually...
This is a $5,108,214.00 cost-plus-award-fee delivery order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke to Mriglobal, a 501(c)(3) not-for-profit research organization also known as Midwest Research Institute. The contract is part of the Drug Manufacturing and Formulation Program (DMFP) indefinite delivery, indefinite quantity (IDIQ) contract. Mriglobal will perform the work in...
This federal contract award, with an ID of 75N91023D00010|75N91024F00001, was issued by the National Cancer Institute, a civilian agency within the U.S. Department of Health and Human Services. The contract, which is not set aside, has a ceiling value of $1,866,116.00 and a completion date of September 17, 2026. The scope of the contract includes the production of a drug substance, conversion of the drug substance to a drug product, filling the drug product into applicators for clinical...